Heidi Morris, Megan Reilly, Huayan Zhang, Xiaoyue Dong, Kathleen Gibbs, Catherine M. Avitabile, Sara B. DeMauro, Nicolas A. Bamat
Children’s Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine. Guangzhou Women and Children’s Medical Center.
United States and China
Journal of Perinatology
J Perinatol 2025;
DOI: 10.1038/s41372-025-02234-z
Abstract
Objective: Identify characteristics associated with death or tracheostomy (D/T) in preterm infants with bronchopulmonary dysplasia (BPD) predominantly managed with non-invasive respiratory support prior to 36 weeks postmenstrual age (PMA).
Study design: Retrospective cohort study at Children’s Hospital of Philadelphia of 134 infants meeting inclusion criteria between 2010 and 2017. Various clinical characteristics were considered as predictor variables of the primary outcome, D/T; those associated at p < 0.10 in bivariable logistic regression were evaluated in multivariable models.
Results: Twenty-one (16%) infants had D/T. Treatment with pulmonary vasodilators and the presence of pulmonary hypertension (PH) on echocardiogram at 36 weeks PMA were associated with D/T in bivariable analyses. Pulmonary vasodilator use remained statistically significant in adjusted multivariable models.
Conclusions: We identified a strong association between PH and D/T in this cohort. Our findings emphasize the importance of specialized BPD management that includes early identification of PH in this high-risk population.
Category
Class III. Pulmonary Hypertension Associated with Lung Disease
Age Focus: Pediatric Pulmonary Vascular Disease
Fresh or Filed Publication: Fresh (PHresh). Less than 1-2 years since publication
Article Access
Free PDF File or Full Text Article Available Through PubMed or DOI: No